A detailed history of Acadian Asset Management LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 944,996 shares of ANNX stock, worth $4.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
944,996
Previous 912,151 3.6%
Holding current value
$4.78 Million
Previous $4.47 Million 25.18%
% of portfolio
0.02%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.49 - $7.2 $147,474 - $236,484
32,845 Added 3.6%
944,996 $5.59 Million
Q2 2024

Aug 06, 2024

SELL
$4.33 - $6.79 $198,495 - $311,267
-45,842 Reduced 4.79%
912,151 $4.47 Million
Q1 2024

May 10, 2024

BUY
$4.03 - $7.81 $338,395 - $655,797
83,969 Added 9.61%
957,993 $6.87 Million
Q4 2023

Feb 13, 2024

BUY
$1.63 - $4.63 $100,734 - $286,134
61,800 Added 7.61%
874,024 $3.97 Million
Q3 2023

Nov 13, 2023

SELL
$2.13 - $3.84 $17,768 - $32,033
-8,342 Reduced 1.02%
812,224 $1.92 Million
Q2 2023

Aug 07, 2023

BUY
$2.1 - $6.37 $32,102 - $97,378
15,287 Added 1.9%
820,566 $2.89 Million
Q1 2023

May 11, 2023

BUY
$3.74 - $7.46 $1.53 Million - $3.05 Million
408,467 Added 102.94%
805,279 $3.1 Million
Q4 2022

Feb 14, 2023

SELL
$4.56 - $6.61 $29,115 - $42,204
-6,385 Reduced 1.58%
396,812 $2.05 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $9,963 - $17,615
2,657 Added 0.66%
403,197 $2.49 Million
Q2 2022

Aug 09, 2022

BUY
$2.11 - $4.06 $543,635 - $1.05 Million
257,647 Added 180.31%
400,540 $1.51 Million
Q1 2022

May 12, 2022

BUY
$2.73 - $11.94 $390,097 - $1.71 Million
142,893 New
142,893 $388,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $241M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.